BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,132 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $14,792,000 | -79.2% | 183,938 | -77.7% | 0.11% | -82.1% |
| Q2 2020 | $71,041,000 | +22.5% | 825,104 | +15.5% | 0.61% | -1.6% |
| Q1 2020 | $58,012,000 | +10.2% | 714,518 | +13.5% | 0.62% | +36.0% |
| Q4 2019 | $52,655,000 | -8.1% | 629,697 | -3.9% | 0.46% | -11.1% |
| Q3 2019 | $57,313,000 | -15.4% | 655,230 | -20.8% | 0.52% | -13.4% |
| Q2 2019 | $67,772,000 | +566.8% | 827,500 | +562.0% | 0.60% | +533.0% |
| Q1 2019 | $10,164,000 | -83.5% | 125,000 | -84.4% | 0.09% | -82.1% |
| Q3 2018 | $61,672,000 | +98.4% | 800,000 | +90.0% | 0.52% | +180.7% |
| Q2 2018 | $31,087,000 | -38.7% | 421,000 | -46.0% | 0.19% | -63.5% |
| Q1 2018 | $50,731,000 | +2.8% | 780,000 | -18.0% | 0.51% | -30.7% |
| Q1 2017 | $49,330,000 | +27.1% | 951,223 | +8.7% | 0.74% | +19.4% |
| Q4 2016 | $38,798,000 | +35.8% | 875,000 | +45.8% | 0.62% | +25.6% |
| Q3 2016 | $28,560,000 | +1.9% | 600,000 | -3.2% | 0.49% | -6.8% |
| Q2 2016 | $28,036,000 | +1536.7% | 620,000 | +2380.0% | 0.53% | +1553.1% |
| Q1 2015 | $1,713,000 | +55.9% | 25,000 | +66.7% | 0.03% | +52.4% |
| Q4 2014 | $1,099,000 | +2.0% | 15,000 | 0.0% | 0.02% | -8.7% |
| Q3 2014 | $1,077,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |